Arvinas, Inc. (ARVN) Revenue Growth
Arvinas, Inc. (ARVN) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2019-12-31 | 200.03% |
| 2020-12-31 | -49.27% |
| 2021-12-31 | 145.87% |
| 2022-12-31 | 145.15% |
| 2023-12-31 | -40.26% |
| 2024-12-31 | 235.54% |
| 2025-12-31 | -0.30% |
How ARVN compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| MNKD | MannKind Corporation | 22.23% |
| NBIX | Neurocrine Biosciences Inc. | 21.45% |
| INCY | Incyte Corporation | 21.22% |
| AQST | Aquestive Therapeutics Inc. | -22.61% |
| EBS | Emergent BioSolutions Inc. | -28.81% |
These are five companies in the same sector as ARVN with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arvinas, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ARVN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARVN | $9.39 | +0.86% | 0.45M |
| 3 | ||||
| 4 | ||||
| 5 |